Left ventricular hypertrophy by electrocardiography and echocardiography in the African American Study of Kidney Disease Cohort Study. 2012

Ricardo Esquitin, and Louai Razzouk, and Gail E Peterson, and Jackson T Wright, and Robert A Phillips, and Tine L De Backer, and David A Baran, and Cynthia Kendrick, and Tom Greene, and James Reiffel, and Paul Muntner, and Michael E Farkouh
Beth Israel Deaconess Medical Center, Boston, MA, USA.

Although electrocardiographic criteria for diagnosing left ventricular hypertrophy have a low sensitivity in the general population, their test characteristics have not been evaluated in the high-prevalence group of American Americans with chronic kidney disease. The purpose of the current study was to evaluate these test characteristics among African Americans (n = 645) with hypertensive kidney disease as part of the African-American Study of Kidney Disease and Hypertension cohort. Electrocardiograms were read by 2 cardiologists at an independent core laboratory using the 2 Sokolow-Lyon criteria and the Cornell criteria. Left ventricular hypertrophy on echocardiography was defined as left ventricular mass index greater than 49.2 and greater than 46.7 g/m(2.7) in men and women, respectively. Sixty-nine percent of the population had left ventricular hypertrophy on echo, whereas 34% had left ventricular hypertrophy by any of the electrocardiographic criteria. Sensitivity by individual electrocardiographic criteria was 16.5% by Sokolow-Lyon-1, 19.3% by Sokolow-Lyon-2, and 24.7% by Cornell criteria, with specificity ranging from 89% to 92%. When using any of the 3 criteria, sensitivity increased to 40.4% with a decrease in specificity to 78.0%. Consistent with findings in a general population, left ventricular hypertrophy by electrocardiography had low sensitivity and high specificity in this cohort of African Americans with hypertensive kidney disease.

UI MeSH Term Description Entries
D006977 Hypertension, Renal Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN. Hypertensions, Renal,Renal Hypertension,Renal Hypertensions
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001741 Black or African American A person having origins in any of the black racial groups of Africa (https://www.federalregister.gov/documents/1997/10/30/97-28653/revisions-to-the-standards-for-the classification-of-federal-data-on-race-and-ethnicity). In the United States it is used for classification of federal government data on race and ethnicity. Race and ethnicity terms are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies. African American,African Americans,African-American,Afro-American,Afro-Americans,Black Americans,Blacks,Negroes,African-Americans,Negro,Afro American,Afro Americans,American, African,American, Black,Black American
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004452 Echocardiography Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic. Echocardiography, Contrast,Echocardiography, Cross-Sectional,Echocardiography, M-Mode,Echocardiography, Transthoracic,Echocardiography, Two-Dimensional,Transthoracic Echocardiography,2-D Echocardiography,2D Echocardiography,Contrast Echocardiography,Cross-Sectional Echocardiography,Echocardiography, 2-D,Echocardiography, 2D,M-Mode Echocardiography,Two-Dimensional Echocardiography,2 D Echocardiography,Cross Sectional Echocardiography,Echocardiography, 2 D,Echocardiography, Cross Sectional,Echocardiography, M Mode,Echocardiography, Two Dimensional,M Mode Echocardiography,Two Dimensional Echocardiography
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead

Related Publications

Ricardo Esquitin, and Louai Razzouk, and Gail E Peterson, and Jackson T Wright, and Robert A Phillips, and Tine L De Backer, and David A Baran, and Cynthia Kendrick, and Tom Greene, and James Reiffel, and Paul Muntner, and Michael E Farkouh
December 2007, Hypertension (Dallas, Tex. : 1979),
Ricardo Esquitin, and Louai Razzouk, and Gail E Peterson, and Jackson T Wright, and Robert A Phillips, and Tine L De Backer, and David A Baran, and Cynthia Kendrick, and Tom Greene, and James Reiffel, and Paul Muntner, and Michael E Farkouh
January 2019, Clinical interventions in aging,
Ricardo Esquitin, and Louai Razzouk, and Gail E Peterson, and Jackson T Wright, and Robert A Phillips, and Tine L De Backer, and David A Baran, and Cynthia Kendrick, and Tom Greene, and James Reiffel, and Paul Muntner, and Michael E Farkouh
February 1978, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
Ricardo Esquitin, and Louai Razzouk, and Gail E Peterson, and Jackson T Wright, and Robert A Phillips, and Tine L De Backer, and David A Baran, and Cynthia Kendrick, and Tom Greene, and James Reiffel, and Paul Muntner, and Michael E Farkouh
January 2009, Kathmandu University medical journal (KUMJ),
Ricardo Esquitin, and Louai Razzouk, and Gail E Peterson, and Jackson T Wright, and Robert A Phillips, and Tine L De Backer, and David A Baran, and Cynthia Kendrick, and Tom Greene, and James Reiffel, and Paul Muntner, and Michael E Farkouh
September 1983, The American journal of medicine,
Ricardo Esquitin, and Louai Razzouk, and Gail E Peterson, and Jackson T Wright, and Robert A Phillips, and Tine L De Backer, and David A Baran, and Cynthia Kendrick, and Tom Greene, and James Reiffel, and Paul Muntner, and Michael E Farkouh
January 1989, Scandinavian journal of clinical and laboratory investigation. Supplementum,
Ricardo Esquitin, and Louai Razzouk, and Gail E Peterson, and Jackson T Wright, and Robert A Phillips, and Tine L De Backer, and David A Baran, and Cynthia Kendrick, and Tom Greene, and James Reiffel, and Paul Muntner, and Michael E Farkouh
October 2018, Pediatric cardiology,
Ricardo Esquitin, and Louai Razzouk, and Gail E Peterson, and Jackson T Wright, and Robert A Phillips, and Tine L De Backer, and David A Baran, and Cynthia Kendrick, and Tom Greene, and James Reiffel, and Paul Muntner, and Michael E Farkouh
November 1997, Nederlands tijdschrift voor geneeskunde,
Ricardo Esquitin, and Louai Razzouk, and Gail E Peterson, and Jackson T Wright, and Robert A Phillips, and Tine L De Backer, and David A Baran, and Cynthia Kendrick, and Tom Greene, and James Reiffel, and Paul Muntner, and Michael E Farkouh
February 1986, Cardiologia (Rome, Italy),
Ricardo Esquitin, and Louai Razzouk, and Gail E Peterson, and Jackson T Wright, and Robert A Phillips, and Tine L De Backer, and David A Baran, and Cynthia Kendrick, and Tom Greene, and James Reiffel, and Paul Muntner, and Michael E Farkouh
October 1997, Nederlands tijdschrift voor geneeskunde,
Copied contents to your clipboard!